Genomics

BBI Scientists Awarded $12.5 Million NIH Grant to Study Genomic Variation Among Cells

May 31, 2023 | by Michael McCarthy, UW Medicine Communications

The new research effort aims to identify genome diversity within cells of different bodily tissues, which affect normal development, aging and our overall health.

Rodent Regeneration: ‘Unique’ Spiny Mouse Genome Offers Potential Scientific Roadmap to Reclaiming Patients’ Damaged or Failing Organs

May 30, 2023 | by BBI Communications

How does a five-inch long rodent native to African and Middle Eastern deserts offer what researchers affiliated with the Brotman Baty Institute believe is the greatest hope for restoring a person’s damaged or failing kidneys, liver, or other internal organs?

Genomic Sequencing Offers Insights into the Life – and Death – of Beethoven

April 02, 2023 | by BBI Communications

Why would the editors of a respected peer-reviewed journal consider, let alone publish, a paper based on five strands of hair from a man who has been dead nearly 150 years?

Miller Lab Offering Targeted, Whole Genome, and Single-Cell Long-Read Sequencing Services

January 09, 2023 | by BBI Communications

BBI’s Dr. Danny Miller and the UW’s Nanopore Sequencing Core providing targeted and whole genome long-read sequencing of both DNA and RNA to assist researchers with projects that could benefit from long-read sequencing technology

BBI Researchers to Present at Upcoming IGVF Conference

September 06, 2022 | by BBI Communications

BBI will be well-represented at the upcoming conference of the Impact of Genomic Variation on Function, (IGVF), September 21 through 23, with presentations by three researchers.

The Future of Precision Medicine: Analogous to the Discovery of the X-Ray and Development of Radiology

June 30, 2022 | by BBI Communications

BBI’s Dr. Colin Pritchard believes that to chart the future of precision medicine, one needs to look no further than the development of radiology.

Genome Sciences Hosting ‘DNA Café' featuring Ice Cream and Genomics

June 28, 2022 | by BBI Communications

Genomics and your favorite ice cream sundae: What could be better?

The Backstory of the First Complete Sequence of the Human Genome

April 29, 2022 | by BBI Communications

A Q&A with BBI researchers reveals why the merger of two sequencing systems was crucial to landmark study

BBI’s Danny Miller Leading New Effort Offering Sequencing Services

April 29, 2022 | by BBI Communications

BBI’s Dr. Danny Miller and the UW’s Nanopore Sequencing Core are providing both targeted and whole genome long read sequencing on the Oxford Nanopore platform to assist other researchers with their projects.

BBI's Dr. Evan Eichler a Lead Author on Paper of First Complete Human Genome Map

April 01, 2022 | by BBI Communications

‘Our view of how humans differ from each other is going to be transformed’

NIH All of Us Research Program releases genomic dataset

March 17, 2022 | by UW Medicine

The nearly 100,000 whole genome sequences reflect contributions from diverse participants.

BAT Lab joining UW Initiative to Combat Wildlife Trafficking

February 17, 2022 | by BBI Communications

The Brotman Baty Institute Advanced Technology Lab (BAT Lab) will soon be evaluating animal and plant specimens as part of a new UW initiative to help combat international wildlife trafficking.

Vancouver Sun profile of Ashley Doyle

February 02, 2022 | by BBI Communications

Ashley Doyle, a client of BBI’s ConnectMyVariant with hereditary cancer, is making a ‘Herculean effort” to connect with relatives near and far, urging them to seek genetic testing.

Chris Evert and the Imperative of Studying Genetic Variants

January 19, 2022 | by Lea Starita

We generate data in our research labs to inform the classification of variants found in people like Chris and Jeanne Evert.

Looking Back and Projecting Ahead as AVE Celebrates One Year

October 21, 2021 | by BBI Communications

This October marks the one-year anniversary of the Atlas of Variant Effects (AVE) Alliance.

BBI’s Dr. Doug Fowler: Q&A on NHGRI’s Bold Predictions for Human Genomics by 2030

September 21, 2021 | by BBI Communications

BBI’s Dr. Doug Fowler on September 16 presented at a National Human Genome Institute’s (NHRGI) “Bold Predictions”: The clinical relevance of all encountered genomic variants will be readily predictable, rendering the diagnostic designation “variant of uncertain significance (VUS)” obsolete.